Participated · Series A · Jun 2022

Siteflow offers a tablet-based software solution initially built for the French nuclear industry that digitises field operations and replaces paper validation with procedure-driven, data-centric workflows. The product captures operational procedures from process engineering departments and lets operators concentrate on technical tasks while improving security, quality and compliance. The company raised €10 million in a Series A to accelerate product development and global expansion. Proceeds will fund new functionality to improve software quality and resilience and to enhance collaboration and data sharing. Siteflow plans to use the funds to drive international expansion across Europe and the U.S. The founders emphasize the platform’s configurability and its applicability across maintenance, construction and decommissioning activities in complex industries.

Participated · Series B · Oct 2019

Herow provides a contextual engagement SaaS platform for mobile applications that uses location intelligence and everyday behaviors to drive user engagement. Its solution lets marketers and developers understand how, when and where apps are used, create user segments based on real-world moments, and deliver contextual notifications and in-app actions. The platform is built to protect personal user data and comply with GDPR and CCPA regulations. Herow was founded in 2007 and is led by CEO Laetitia Gazel Anthoine. The company has offices in Paris, New York, Barcelona and San Francisco. It recently closed new funding to support deployment and expansion of its contextual engagement offering.

Participated · Equity · Mar 2019

Implicity is a Cambridge, MA–based software company offering a universal cardiac remote monitoring and research platform for clinics and service companies. Its AI-based technology and cardiac data management solutions include an FDA-cleared algorithm that analyzes ECG episodes from implantable loop recorders. The platform enables healthcare professionals to take a more holistic approach to caring for cardiac patients. The company supports more than 60,000 patients across 100 medical facilities in the United States and Europe. Led by CEO Dr. Arnaud Rosier, Implicity plans to use new funding to increase its US market presence and expand into new markets. It also intends to develop additional medical device software to strengthen its technological leadership. Implicity provides a universal platform that aggregates transmissions from cardiac implantable electronic devices (pacemakers and defibrillators) across vendors and uses AI to contextualize device data with patients' medical records. The tool enables physicians to remotely track connected patients, filter alerts, and deliver personalized telemedicine to optimize medical resources. After one year of deployment in France the platform follows more than 8,000 patients (reported as over 10% of patients on the platform) across about twenty public and private hospitals and participates in the ETAPES program that allows teams to bill €130 per patient per year. The product targets the fragmentation caused by vendor-specific platforms (Abbott, Biotronik, Boston Scientific, Medtronic and Microport) by offering a single interface for hospitals. Founded in May 2016 by Dr. Arnaud Rosier with David Perlmutter and Louis Pinot and headquartered in Paris, Implicity positions itself as a French leader in digitalizing CIED monitoring. The company plans to strengthen sales and marketing across France and Europe, deploy a first U.S. data center in 2019, and accelerate development and commercialization of new AI algorithms to improve prognosis and follow-up while reducing health resource use.

Participated · Equity · Feb 2018

Founded in 2016, Innovafeed develops technology to rear and transform the Black Soldier Fly (Hermetia illucens) at industrial scale to produce protein and oil ingredients for animal and plant nutrition. Its proprietary, sensor-driven and partially robotic production process and wet transformation method aim to optimise breeding conditions and product digestibility. The company says its Nesle production unit is fully operational and has produced over 15,000 tons of protein and oil in three years while increasing volumes tenfold and cutting production costs by seven. Innovafeed plans to prioritise commercial deployment of its Hilucia™ product ranges—particularly in functional segments of aquaculture and pet food—while redirecting investment toward industrial equipment, applications development, and operational excellence. As part of this new phase the company is reorganising activities around Nesle, integrating R&D from Gouzeaucourt and planning a workforce reduction tied to that integration. Innovafeed reports strong commercial traction with revenues doubling annually and emphasizes the environmental benefits of its circular industrial model.

Participated · Equity · Apr 2016

Acco Semiconductor is a fabless semiconductor company that develops CMOS RF front-end components for mobile devices and IoT. It focuses on critical RF front-end components including Multi-mode Multi-band Power Amplifiers (MMPA) manufactured in standard high-volume bulk CMOS processes. The company has developed and patented RF front-end technology for mobile communications devices, including power amplifiers and antenna switches that use standard CMOS processing. Led by President and CEO Greg Caltabiano, Acco is accelerating its business into various brands of LTE smartphones across several countries in Asia and Europe. The company intends to use the funds to launch a new generation of industry-standard RF front-end CMOS solutions, support R&D for next-generation products, and add incremental local support for its customer base. Acco is based in Sunnyvale, California and Paris, France.